During the past decade, Saint Vincent Hospital Cancer Center at Marinette conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 11 clinical trials were completed, i.e. on average, 25.6% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 11 clinical trials were completed. i.e. 137.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Vincent Hospital Cancer Center at Marinette" #1 sponsor was "National Cancer Institute (NCI)" with 23 trials, followed by "SWOG Cancer Research Network" with 8 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "Wake Forest University Health Sciences" with 4 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Vincent Hospital Cancer Center at Marinette" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Saint Vincent Hospital Cancer Center at Marinette" are "Breast Carcinoma" (3 trials), "Fallopian Tube Transitional Cell Carcinoma" (3 trials), "Invasive Breast Carcinoma" (3 trials), "Ovarian Transitional Cell Carcinoma" (3 trials) and "Recurrent Breast Carcinoma" (3 trials). Many other conditions were trialed in "Saint Vincent Hospital Cancer Center at Marinette" in a lesser frequency.

Most popular intervention types in "Saint Vincent Hospital Cancer Center at Marinette" are "Drug" (35 trials), "Other" (32 trials), "Biological" (22 trials), "Procedure" (17 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (14 trials), "Laboratory Biomarker Analysis" (13 trials), "Biospecimen Collection" (12 trials), "Computed Tomography" (12 trials) and "Nivolumab" (11 trials). Other intervention names were less common.

The vast majority of trials in "Saint Vincent Hospital Cancer Center at Marinette" are 42 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Saint Vincent Hospital Cancer Center at Marinette". undefined are not yet recruiting, 7 are recruiting, 34 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Saint Vincent Hospital Cancer Center at Marinette, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Vincent Hospital Cancer Center at Marinette, 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".